Literature DB >> 984777

In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents.

R J Duma, R Finley.   

Abstract

Six pathogenic strains of Naegleria fowleri, two of Acanthamoeba castellanii, and three of Acanthamoeba polyphaga were tested in vitro for susceptibility to a variety of potentially useful therapeutic agents. Minimal motility inhibitory concentrations and minimal inhibitory concentrations were determined by a technique of subculturing pure clones of amoebae in plastic tissue culture chamber slides containing liquid axenic media and serially diluted drug, incubating at 30 degrees C for Acanthamoeba and at 37 degrees C for Naegleria, and observing on an inverted microscope at 6 h for inhibition of motility and at 24 and 48 h for inhibition of growth. Drug concentrations were selected on the basis of fluid levels achievable in humans. Amphotericin B, clotrimazole, and miconazole were the most effective drugs against Naegleria, whereas polymyxin B sulfate and pentamidine isethionate were somewhat effective against pathogenic Acanthamoeba. Our results suggest that amphotericin B is the most effective agent against Naegleria, but few agents are effective against Acanthamoeba.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984777      PMCID: PMC429749          DOI: 10.1128/AAC.10.2.370

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Primary amoebic meningoencephalitis.

Authors:  R J Duma
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1972-06

Review 2.  Primary amoebic meningo-encephalitis. An appraisal of present knowledge.

Authors:  R F Carter
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

3.  Letter: Primary amoebic meningoencephalitis.

Authors:  A Jamieson; K Anderson
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

4.  Brain abscesses caused by free-living amoeba probably of the genus Hartmannella in a patient with Hodgkin's disease.

Authors:  B V Jager; W P Stamm
Journal:  Lancet       Date:  1972-12-23       Impact factor: 79.321

5.  In vitro and in vivo activity of 5-fluorocytosine on Acanthamoeba.

Authors:  A R Stevens; W D O'Dell
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

6.  Amoebic infection of the eye.

Authors:  J Naginton; P G Watson; T J Playfair; J McGill; B R Jones; A D Steele
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

7.  Description of a Naegleria sp. isolated from two cases of primary amoebic meningo-encephalitis, and of the experimental pathological changes induced by it.

Authors:  R F Carter
Journal:  J Pathol       Date:  1970-04       Impact factor: 7.996

8.  Primary amebic meningoencephalitis.

Authors:  C G Butt
Journal:  N Engl J Med       Date:  1966-06-30       Impact factor: 91.245

9.  Animal model of human disease. Primary amebic meningoencephalitis, Naegleria meningoencephalitis, CNS protozoal infection.

Authors:  A J Martinez; E C Nelson; R J Duma
Journal:  Am J Pathol       Date:  1973-11       Impact factor: 4.307

10.  Experimental pneumonitis and encephalitis caused by acanthamoeba in mice: pathogenesis and ultrastructural features.

Authors:  A J Martinez; S M Markowitz; R J Duma
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

View more
  19 in total

1.  Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Soltow; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

2.  HMG-CoA Reductase Inhibitors as Drug Leads against Naegleria fowleri.

Authors:  Hye Jee Hahn; Ruben Abagyan; Larissa M Podust; Shantanu Roy; Ibne Karim M Ali; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-09-19       Impact factor: 4.418

3.  Evaluation of in vitro activity of five antimicrobial agents on Acanthamoeba isolates and their toxicity on human corneal epithelium.

Authors:  Kirti Megha; Megha Sharma; Chayan Sharma; Amit Gupta; Rakesh Sehgal; Sumeeta Khurana
Journal:  Eye (Lond)       Date:  2021-09-21       Impact factor: 4.456

4.  In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination.

Authors:  K K Lee; S L Karr; M M Wong; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

5.  Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis.

Authors:  Rebecca A Kuennen; Reynell Harder Smith; Thomas F Mauger; Elson Craig
Journal:  Clin Ophthalmol       Date:  2010-10-05

6.  Acanthamoebic keratitis diagnosed by paracentesis and biopsy and treated with propamidine.

Authors:  K McClellan; D J Coster
Journal:  Br J Ophthalmol       Date:  1987-10       Impact factor: 4.638

Review 7.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

8.  Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Goswick; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

9.  Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro.

Authors:  Jose Ignacio Escrig; Hye Jee Hahn; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-05-26       Impact factor: 4.418

10.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.